509
Views
7
CrossRef citations to date
0
Altmetric
Articles

Efficacy and Safety of a Traditional Herbal Combination in Patients with Type II Diabetes Mellitus: A Randomized Controlled Trial

, PhD, , MSc, , MD, PhD, , MD, , MSc & , PhD

References

  • Abidov M, Ramazanov A, Jimenez Del Rio M, Chkhikvishvili I. 2006. Effect of Blueberin on fasting glucose, C-reactive protein and plasma aminotransferases, in female volunteers with diabetes type 2: double-blind, placebo controlled clinical study. Georgian Med News. 141:66–72.
  • Ajabnoor MA, Tilmisany AK. 1988. Effect of Trigonella foenum graceum on blood glucose levels in normal and alloxan-diabetic mice. J Ethnopharmacol. 22(1):45–9. doi:10.1016/0378-8741(88)90229-2.
  • Amiri Behzadi A, Kalalian-Moghaddam H, Ahmadi AH. 2016. Effects of Urtica dioica supplementation on blood lipids, hepatic enzymes and nitric oxide levels in type 2 diabetic patients: A double blind, randomized clinical trial. Avicenna J Phytomed. 6(6):686–95.
  • Chang C-C, Yang M-H, Wen H-M, Chern J-C. 2002. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal. 10:178–182.
  • Chen SJ, Aikawa C, Yoshida R, Kawaguchi T, Matsui T. 2017. Anti-prediabetic effect of rose hip (Rosa canina) extract in spontaneously diabetic Torii rats. J Sci Food Agric.Agric. 97(12):3923–8. doi:10.1002/jsfa.8254.
  • Derosa G, D'Angelo A, Maffioli P. 2016. The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus. Clin Nutr. 35(5):1091–5. doi:10.1016/j.clnu.2015.08.004.
  • Ebrahimpour Koujan S, Gargari BP, Mobasseri M, Valizadeh H, Asghari-Jafarabadi M. 2015. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial. Phytomedicine. 22(2):290–6. doi:10.1016/j.phymed.2014.12.010.
  • Eddouks M, Lemhadri A, Hebi M, El Hidani A, Zeggwagh NA, El Bouhali B, Hajji L, Burcelin R. 2017. Capparis spinosa L. aqueous extract evokes antidiabetic effect in streptozotocin-induced diabetic mice. Avicenna J Phytomed. 7(2):191–8.
  • Eddouks M, Lemhadri A, Michel JB. 2004. Caraway and caper: potential anti-hyperglycaemic plants in diabetic rats. J Ethnopharmacol. 94(1):143–8. doi:10.1016/j.jep.2004.05.006.
  • Eddouks M, Lemhadri A, Michel JB. 2005. Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats. J Ethnopharmacol. 98(3):345–50. doi:10.1016/j.jep.2005.01.053.
  • Fallah Huseini H, Hooseini P, Heshmat R, Yazdani D, Rahmani M, Hemati Moqadam H, Larijani B, Alavi S. 2006. The clinical investigation of securigera securidaca (L.)(degen & doerfler) seeds in type II diabetic patients a randomized, double-blind, placebo-controlled study. J Med Plants. 4:75–9.
  • Farnam A, Rafeey M, Farhang S, Khodjastejafari S. 2009. Functional constipation in children: does maternal personality matter? Ital J Pediatr. 35(1):25. doi:10.1186/1824-7288-35-25.
  • Farzami B, Ahmadvand D, Vardasbi S, Majin FJ, Khaghani S. 2003. Induction of insulin secretion by a component of Urtica dioica leave extract in perifused Islets of Langerhans and its in vivo effects in normal and streptozotocin diabetic rats. J Ethnopharmacol. 89(1):47–53. doi:10.1016/S0378-8741(03)00220-4.
  • Fattahi A, Niyazi F, Shahbazi B, Farzaei MH, Bahrami G. 2017. Antidiabetic Mechanisms of Rosa canina Fruits: An In Vitro Evaluation. J Evid Based Complementary Altern Med. 22(1):127–33. doi:10.1177/2156587216655263.
  • Feshani AM, Kouhsari SM, Mohammadi S. 2011. Vaccinium arctostaphylos, a common herbal medicine in Iran: molecular and biochemical study of its antidiabetic effects on alloxan-diabetic Wistar rats. J Ethnopharmacol. 133(1):67–74. doi:10.1016/j.jep.2010.09.002.
  • Hasani-Ranjbar S, Zahedi HS, Abdollahi M, Larijani B. 2013. Trends in publication of evidence-based Traditional Iranian medicine in endocrinology and metabolic disorders. J Diabetes Metab Disord. 12(1):49. doi:10.1186/2251-6581-12-49.
  • Hashempur MH, Heydari M, Mosavat SH, Heydari ST, Shams M. 2015. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. J Integr Med. 13(5):319–25. doi:10.1016/S2095-4964(15)60196-0.
  • Huseini HF, Hasani-Rnjbar S, Nayebi N, Heshmat R, Sigaroodi FK, Ahvazi M, Alaei BA, Kianbakht S. 2013. Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Complement Ther Med. 21:447–52. doi:10.1016/j.ctim.2013.07.003.
  • Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M. 2006. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 20(12):1036–9. doi:10.1002/ptr.1988.
  • Jalali MT, Mohammadtaghvaei N, Larky DA. 2016. Investigating the effects of Capparis Spinosa on hepatic gluconeogenesis and lipid content in streptozotocin-induced diabetic rats. Biomed Pharmacother. 84:1243–8. doi:10.1016/j.biopha.2016.10.061.
  • Kazemian M, Abad M, Haeri MR, Ebrahimi M, Heidari R. 2015. Anti-diabetic effect of Capparis spinosa L. root extract in diabetic rats. Avicenna J Phytomed. 5(4):325–32.
  • Khalili N, Fereydoonzadeh R, Mohtashami R, Mehrzadi S, Heydari M, Huseini HF. 2017. Silymarin, olibanum, and nettle, a mixed herbal formulation in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. J Evid Based Complementary Altern Med. 22(4):603–8. doi:10.1177/2156587217696929.
  • Khazim K, Gorin Y, Cavaglieri RC, Abboud HE, Fanti P. 2013. The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo. Am J Physiol Renal Physiol. 305(5):F691–700. doi:10.1152/ajprenal.00028.2013.
  • Kianbakht S, Abasi B, Dabaghian FH. 2013. Anti-hyperglycemic effect of Vaccinium arctostaphylos in type 2 diabetic patients: a randomized controlled trial. Forsch Komplementmed. 20(1):17–22. doi:10.1159/000346607.
  • Kianbakht S, Khalighi-Sigaroodi F, Dabaghian FH. 2013. Improved glycemic control in patients with advanced type 2 diabetes mellitus taking Urtica dioica leaf extract: a randomized double-blind placebo-controlled clinical trial. Clin Lab. 59(9–10):1071–6. doi:10.7754/clin.lab.2012.121019.
  • Kim J, Shin W. 2014. How to do random allocation (randomization). Clin Orthop Surg. 6(1):103–9. doi:10.4055/cios.2014.6.1.103.
  • Lu FR, Shen L, Qin Y, Gao L, Li H, Dai Y. 2008. Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus. Chin J Integr Med. 14(1):56–60. doi:10.1007/s11655-007-9005-3.
  • McDonald S, Prenzler PD, Antolovich M, Robards K. 2001. Phenolic content and antioxidant activity of olive extracts. Food Chem. 73(1):73–84. doi:10.1016/S0308-8146(00)00288-0.
  • Neelakantan N, Narayanan M, de Souza RJ, van Dam RM. 2014. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials. Nutr J. 13(1):7. doi:10.1186/1475-2891-13-7.
  • Nickavar B, Amin G. 2011. Enzyme Assay Guided Isolation of an alpha-Amylase Inhibitor Flavonoid from Vaccinium arctostaphylos Leaves. Iran J Pharm Res. 10(4):849–53.
  • Orhan N, Aslan M, Hosbas S, Deliorman OD. 2009. Antidiabetic effect and antioxidant potential of Rosa canina fruits. Phcog Mag. 5:309. doi:10.4103/0973-1296.58151.
  • Philippe J, Raccah D. 2009. Treating type 2 diabetes: how safe are current therapeutic agents? Int J Clin Pract. 63(2):321–32. doi:10.1111/j.1742-1241.2008.01980.x.
  • Porchezhian E, Ansari S. 2001. Effect of Securigera securidaca on blood glucose levels of normal and alloxan-induced diabetic rats. Pharm Biol. 39(1):62–4. doi:10.1076/phbi.39.1.62.5949.
  • Rafieian-Kopaie M, Nasri H. 2012. Silymarin and diabetic nephropathy. J Renal Inj Prev. 1(1):3–5. doi:10.12861/jrip.2012.02.
  • Rafraf M, Malekiyan M, Asghari-Jafarabadi M, Aliasgarzadeh A. 2014. Effect of fenugreek seeds on serum metabolic factors and adiponectin levels in type 2 diabetic patients. Int J Vitam Nutr Res. 84(3–4):196–205. doi:10.1024/0300-9831/a000206.
  • Reddy SS. 2000. Health outcomes in type 2 diabetes. Int J Clin Pract Suppl. 113:46–53.
  • Sheela N, Jose MA, Sathyamurthy D, Kumar BN. 2013. Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats. Iran J Kidney Dis. 7(2):117–23.
  • Shokoohi R, Kianbakht S, Faramarzi M, Rahmanian M, Nabati F, Mehrzadi S, Huseini HF. 2017. Effects of an herbal combination on glycemic control and lipid profile in diabetic women: a randomized, double-blind, placebo-controlled clinical trial. J Evid Based Complementary Altern Med. 22(4):798–804. doi:10.1177/2156587217737683.
  • Shokrzadeh M, Mirshafa A, Yekta Moghaddam N, Birjandian B, Shaki F. 2018. Mitochondrial dysfunction contribute to diabetic neurotoxicity induced by streptozocin in mice: protective effect of Urtica dioica and pioglitazone. Toxicol Mech Methods. 28(7):499–506. doi:10.1080/15376516.2018.1459993.
  • Shokrzadeh M, Sadat-Hosseini S, Fallah M, Shaki F. 2017. Synergism effects of pioglitazone and Urtica dioica extract in streptozotocin-induced nephropathy via attenuation of oxidative stress. Iran J Basic Med Sci. 20(5):497–502. doi:10.22038/IJBMS.2017.8673.
  • Tabatabaei-Malazy O, Ramezani A, Atlasi R, Larijani B, Abdollahi M. 2016. Scientometric study of academic publications on antioxidative herbal medicines in type 2 diabetes mellitus. J Diabetes Metab Disord. 15(1):48. doi:10.1186/s40200-016-0273-3.
  • Taghizadeh M, Rashidi AA, Taherian AA, Vakili Z, Mehran M. 2018. The protective effect of hydroalcoholic extract of Rosa canina (Dog Rose) fruit on liver function and structure in Streptozotocin-induced diabetes in rats. J Diet Suppl. 15(5):624–35. doi:10.1080/19390211.2017.1369205.
  • Taghizadeh M, Rashidi AA, Taherian AA, Vakili Z, Sajad Sajadian M, Ghardashi M. 2016. Antidiabetic and antihyperlipidemic effects of ethanol extract of Rosa canina L. fruit on diabetic rats: an experimental study with histopathological evaluations. J Evid Based Complementary Altern Med. 21(4):Np25–30. doi:10.1177/2156587215612626.
  • Tofighi Z, Moradi-Afrapoli F, Ebrahimi SN, Goodarzi S, Hadjiakhoondi A, Neuburger M, Hamburger M, Abdollahi M, Yassa N. 2017. Securigenin glycosides as hypoglycemic principles of Securigera securidaca seeds. J Nat Med. 71(1):272–80. doi:10.1007/s11418-016-1060-7.
  • Vahid H, Rakhshandeh H, Ghorbani A. 2017. Antidiabetic properties of Capparis spinosa L. and its components. Biomed Pharmacother. 92:293–302. doi:10.1016/j.biopha.2017.05.082.
  • Zarshenas MM, Khademian S, Moein M. 2014. Diabetes and related remedies in medieval Persian medicine. Indian J Endocr Metab. 18(2):142–9. doi:10.4103/2230-8210.129103.
  • Zarvandi M, Rakhshandeh H, Abazari M, Shafiee-Nick R, Ghorbani A. 2017. Safety and efficacy of a polyherbal formulation for the management of dyslipidemia and hyperglycemia in patients with advanced-stage of type-2 diabetes. Biomed Pharmacother. 89:69–75. doi:10.1016/j.biopha.2017.02.016.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.